Orphazyme is a Denmark-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurodegenerative diseases.
$14.8M
Mar 08, 2017
-
Orphazyme is a Denmark-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurodegenerative diseases.
$24M
Jan 08, 2015
-
Avantium is a Netherlands-based chemical technology company that develops and commercializes bio-based plastics and chemical products for industrial applications.
$50M
Jun 04, 2014
-
F-star is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases.
$12.9M
Oct 23, 2013
-
Orphazyme is a Denmark-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurodegenerative diseases.
$20M
Sep 06, 2011
-
Frequently Asked Questions about Aescap
What is Aescap investing in?
Aescap has invested in 11 companies including Orphazyme, Orphazyme and Avantium
What company did Aescap invest in?
Aescap invested in a total 11 companies including Orphazyme, Orphazyme and Avantium
What are the top 5 investments by Aescap?
The top companies in which Aescap invested are Orphazyme, Orphazyme, Avantium, F-star and Orphazyme
